Advertisement

Topics

Charles River investing in expanded biologics partnership with PathoQuest

12:24 EDT 16 Apr 2018 | Outsourcing-Pharma

Charles River Laboratories and PathoQuest have expanded their strategic partnership to help move vaccine, biologic, and gene-therapy candidates through the drug discovery and development pipeline.

Original Article: Charles River investing in expanded biologics partnership with PathoQuest

NEXT ARTICLE

More From BioPortfolio on "Charles River investing in expanded biologics partnership with PathoQuest"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...